Pathway-based feature selection algorithms identify genes discriminating
  patients with multiple sclerosis apart from controls by Zhang, Lei et al.
 1 
Pathway-based feature selection algorithms identify genes 
discriminating patients with multiple sclerosis apart from controls 
 
 Lei Zhang1,2, Linlin Wang1, Pu Tian1§, Suyan Tian3§ 
 
1 School of Life Science, Jilin University, 2699 Qianjin Street, Changchun, Jilin, China, 130012 
2 Department of Neurology, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 
Jilin, China, 130041 
3 Division of Clinical Epidemiology, The First Hospital of Jilin University, 71Xinmin Street, Changchun, 
Jilin, China, 130021 
 
§Corresponding authors 
 
 
Email addresses: 
             
                  
ST: stian@rockefeller.edu 
PT: tianpu@jlu.edu.cn  
 
 2 
Abstract 
Introduction  
The focus of analyzing data from microarray experiments and extracting biological insight from such 
data has experienced a shift from identification of individual genes in association with a phenotype to 
that of biological pathways or gene sets. Meanwhile, feature selection algorithm becomes imperative to 
cope with the high dimensional nature of many modeling tasks in bioinformatics. Many feature selection 
algorithms use information contained within a gene set as a biological priori, and select relevant features 
by incorporating such information. Thus, an integration of gene set analysis with feature selection is 
highly desired. Significance analysis of microarray to gene-set reduction analysis (SAM-GSR) algorithm 
is a novel direction of gene set analysis, aiming at further reduction of gene set into a core subset. Here, 
we explore the feature selection trait possessed by SAM-GSR and then modify SAM-GSR specifically 
to better fulfill this role. 
Results and Conclusions  
Training on a multiple sclerosis (MS) microarray data using both SAM-GSR and our modification of 
SAM-GSR, excellent discriminative performance on an independent test set was achieved. To conclude, 
absorbing biological information from a gene set may be helpful for classification and feature selection. 
Discussion  
Given the fact the complete pathway information is far from completeness, a statistical method capable 
of constructing biologically meaningful gene networks is in demand. The basic requirement is that 
interplay among genes must be taken into account. 
Keywords:  
Gene set analysis; feature selection; multiple sclerosis (MS); microarray; significance analysis of 
microarray (SAM)  
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Introduction  
With the development of several major databases which organize different types of biological pathway 
or gene set information, e.g., Kyoto Encyclopedia of Gene and Genomes (KEGG) [1] and Gene 
Ontology (GO) [2], the coordinated effect of a pathway or gene set as a whole has been explored.  
Subsequently, many pathway or gene-set based methods have been proposed [3–11]. Meanwhile, the 
focus of analyzing data from microarray experiments and extracting biological insight from such data 
have experienced a shift from identification of individual genes in association with a phenotype to that 
of biological pathways or gene sets.  
 
A gene set analysis requires extra consideration than individual gene analysis, namely, the incorporation 
of the whole gene set into an association measure [12]. A gene set analysis can be stratified into two 
major categories based on the formulation of null hypothesis, namely, a ‘self-contained’ test and a 
‘competitive’ test [13]. While the former only considered the expression values of genes within a gene 
set, the latter required some comparison between the gene expression values of gene set being tested and 
those of the genes outside. Many researchers give preference to a ‘self-contained’ test [14]. However, 
the Gene Set Enrichment Analysis (GSEA) [5], a more competitive-like gene set test, gains the top 
popularity. Despite that GSEA has its own advantages, it has been widely criticized for suffering many 
drawbacks [10,12,15] even after major modifications had been specifically made to address some of 
those. In this article, without causing confusion the phrases “gene set” and “pathway” are used 
interchangeably. 
 
Nowadays, feature selection algorithm becomes imperative to cope with the high dimensional nature of 
many modeling tasks in bioinformatics [16]. Among a variety of feature selection algorithms, many use 
information contained within a gene set as a biological priori and select relevant features by 
incorporating such information. An important finding is the incorporation of such gene set information 
can potentially increase the predictive power of a classifier and identify more biological meaningful 
features [8,17,18]. For instance, Ma et al [19] proposed a supervised group Lasso method which can 
divide genes into clusters by incorporating the gene set information. Briefly, this method consists of two 
steps. First, identification of relevant genes within each cluster using Lasso method was conducted. 
Then the effort was devoted to select relevant clusters using the group Lasso. Of note, the authors 
mentioned they defined cluster structure based on statistical measurements such as a K-mean method, 
given gene set information is only partially available or even not available for the genes under 
consideration. Thus the clusters constructed by this means are mutually exclusive and no genes are 
excluded due to lack of biological information in the annotated databases. Nevertheless, in reality it is 
routine to have a single gene involving in many gene sets or pathways. Another example is the one 
suggested by [20]. In this algorithm, a pseudo-gene taking the average value of all genes within a gene 
set was created to represent the whole gene subset, and then the downstream analysis was conducted 
using those pseudo-genes. Such a method leads to results with poor biological interpretation, and is in 
vain for selecting relevant genes.  
 
A more relevant direction of gene set analysis was proposed by [15], which aimed at further reduction of 
gene set into a core subset. The authors claimed that reducing a significant gene set to core subset is an 
essential step towards understanding biological mechanisms underlying the gene-set association with the 
phenotype of interest. The reasons they gave to support this statement include 1) a smaller set of genes is 
easier to understand and facilitate biological insight into disease processes, and 2) reduction to the most 
predictive genes allows for targeted therapies and intervention strategies, and 3) such reduction 
facilitates a downsize of platform from a high-throughput microarray technology to cheaper and quicker 
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methods such as real-time PCR, thus increases the applicability for diagnostic purposes in a clinical 
setting. The proposed method was named as significance analysis of microarray to gene set reduction 
analysis (SAM-GSR). Obviously, those issues are also targeted by a feature selection algorithm, which 
motivates us to conduct feature selection based on the selected gene sets, using SAM-GSR algorithm.   
 
Multiple sclerosis (MS) is the most prevalent demyelinating disease and the principal cause of 
neurological disability in young adults [21]. Diagnosis of MS can only be confirmed currently using 
invasive and expensive tests such as magnetic resonance imaging (MRI). Therefore, researchers have 
beginning to resort to other technologies for an easier and cheaper diagnosis of MS. Among them, 
microarray technology is the one being extensively explored [22–24] even though compared to its 
popularity in cancer research, the number of microarray experiments on MS is limited and the sample 
sizes of those studies are predominately small [25]. A combination of an integrated microarray data set 
and a suitable computational algorithm to classify MS samples is highly desirable. Fortunately, as a part 
of the recently-launched systems biology verification (sbv) Industrial Methodology for Process 
Verification in Research (IMPROVER) Challenge [26], MS diagnosis sub-challenge targeted 
specifically on this issue, using gene expression data obtained from microarray experiments. Among the 
challenge participants who ranked high in this sub-challenge, two pieces of work were relevant to gene-
set based analysis. First, Lauria [27] used Cytoscape [28] to construct two separate clusters/networks to 
discriminate MS samples from controls. However, the modeling parsimony was not a concern in this 
method. Therefore, the results might be not applicable in the clinical setting. In contrast, Zhao et al [29] 
implemented the method by Chen et al. [20] and generated one pseudo-gene for each pathway by 
averaging expression values of all genes in that pathway. Then a logistic regression with elastic net 
regularization with the resulting pseudo-features was fitted. Nevertheless, it turned out such method was 
inferior to their final model in which the individual genes serving as covariates in a regularized logistic 
regression model.  
 
In this paper, we explore the feature selection trait possessed by SAM-GSR and make specifically some 
modification on it to better fulfill this role. The results from our analyses indicate absorbing biological 
information from a gene set may be helpful to identify relevant genes with good discriminative 
performance.     
 
Methods and Materials 
Experimental data  
The training data includes chips from the experiment E-MTAB-69 stored in the ArrayExpress [30] 
repository (http://www.ebi.ac.uk/arrayexpress). All chips were hybridized on Affymetrix HGU133 Plus 
2.0 chips. In this study, there were 26 patients with relapsing-remitting multiple sclerosis (RRMS) and 
18 controls with neurological disorders of a non-inflammatory nature.  
The test dataset is the one used in the IMPROVER MS sub-challenge, which is accessible to the 
challenge participants on the project website (http://www.sbvimprover.com). It was hybridized on 
Affymetrix HGU133 Plus 2.0, and there were 28 patients with RRMS and 32 normal controls. 
The gene sets were downloaded from the Molecular Signatures Database (MSigDB) [5]. First, we 
considered c2 category. This category includes gene sets from curated pathways databases such as 
KEGG and those manually curated from the literature on gene expression. The current version (version 
4.0) of MSigDB c2 category included 4,722 gene sets annotating on 11,844 unique genes. Similarly, the 
genes sets in c5 category were downloaded as well, including 1,454 gene sets annotated by GO terms.   
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Pre-processing procedures   
Raw data of the training set was downloaded from the ArrayExpress repository, and expression values 
were obtained using the GCRMA algorithm [31] and normalization across samples was carried out using 
quantile normalization. The resulting expression values were on log2 scale. When there were multiple 
probe sets representing the same gene, the one with the largest fold change as indicated by the 
moderated t-tests was chosen. Then the resulting expression values of 19,851 unique genes were fed into 
downstream analysis. Raw data of the test set was downloaded from the sbv challenge website, and was 
pre-processed in the same way.  
Methods  
SAM-GSR 
As mentioned in the Introduction section, SAM-GSR is an extension of SAM-GS with the objective of 
core subset identification. Briefly, the following statistic was defined for gene set j in SAM-GS, 
SAM −GSj = di2
i=1
| j|
∑ , di = (xd (i)− xc (i)) / (s(i)+ s0 )  
where di is SAM statistic [32] and calculated for each gene involving in a gene set, xd (i)  and xc (i) are 
the sample averages of gene i respectively for diseased group and control group, s(i) is a pooled standard 
deviation and estimated by pooling samples over two groups, s0 is a small positive constant used to 
offset the small variability in microarray measurements, and |j| is the size of gene set j. Thus, SAM-GSR 
statistic for a gene set is the L2 norm of SAM statistics for all genes within the gene set.  
Upon a significant gene set, where statistical significance is estimated using a permutation test by 
perturbing phenotype-labels for several hundred times, SAM-GSR gradually partitions the entire set 
S into two subsets: the reduced subset Rk and the residual one Rk for k=1,…, |j|. Here, genes in gene set j 
are ordered decreasingly based on the magnitude of SAM statistic di. Let ck be the SAM-GS p-value of 
Rk , the final Rk corresponds to the least k so that ck is larger than a threshold. The choice for this 
threshold is very liberal and varies from one application to another. For more details on SAM-GSR, the 
original work [15] is referred.  
Our modifications to SAM-GSR  
In SAM-GSR, the significant level of a gene within a gene set is determined by its contribution to the 
SAM-GS statistic. It implies that if in a gene set |di|> |dj| for genes i and j, gene j is not be inside the 
reduce subset when gene i is not. However, when the goal is feature selection, the magnitude of 
individual SAM statistic is not the focus. Therefore, we propose to use a penalized machine learning 
method to perform feature selection automatically and classify samples simultaneously. Because support 
vector machine (SVM) [33] is one of widely used and extremely powerful supervised learning methods, 
especially suitable for the two-class classification tasks of microarray data [34], we propose to use a 
SVM classifier with a Smoothly Clipped Absolute Deviation (SCAD) [35,36] function as the penalty to 
do feature selection. The final tuning parameter in SVM-SCAD was selected using 5-fold cross 
validation. The extension of SAM-GSR for feature selection purpose is referred to as modified SAM-
GSR herein.   
 
Notably, because in SAM-GSR posterior probability of each sample is not computable, we use SVM to 
do classification and posterior probability calculations. The choice of SVM here is to keep consistent to 
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analyses using modified SAM-GSR. Moreover, the cutoff values of ck in SAM-GSR are different among 
individual analysis. A grid of values (i.e., 0.05 to 0.5 with an increment of 0.05) is considered and the 
one achieving the best classification rate and the smallest size on training set is chosen. Figure 1 
illustrates graphically on both SAM-GSR and modified SAM-GSR algorithms.   
Weighted co-expression networks 
Weighted co-expression network (http://www.genetics.ucla.edu/labs/horvath/CoexpressionNetwork) is 
one method to build mutually exclusive networks describing co-expression patterns among multiple 
genes. Because pathway information contained in the MSigDB database is incomplete or not available 
for many genes, those genes are consequently eliminated from the downstream analyses. To evaluate if 
such elimination causes any miss-out of potential relevant genes, we use the gene sets constructed by the 
weighted co-expression network algorithm to reanalyze the data, and make comparisons. For a brief 
description on the weighted co-expression network algorithm, the article by Ma et al. [8] is a good 
reference.  
Statistical Metrics 
Usually, using a single metric to evaluate an algorithm tends to produce bias, where an algorithm may 
be erroneously claimed to be superior if a metric favouring it is chosen [26]. Thus we use four metrics, 
namely, Belief Confusion Metric (BCM), Area Under the Precision-Recall Curve (AUPR), Generalized 
Brier Score (GBS), and error rate, to evaluate the performance of a classifier. For the detailed 
description on GBS, the following work [37,38] is referred. For BCM and AUPR, two metrics used by 
SBV challenge, their definition and interpretation are available in the SBV homepage 
(http://www.sbvimprover.com/sites/default/files/scoring_metrics.pdf). Briefly, BCM captures the 
average belief/confidence that a sample belongs to a class when indeed it belongs to this class, while 
AUPR summarizes the ability to correctly rank the samples known to be in a given class when sorted by 
the belief values decreasingly for that class, as summarized by [39].    
Statistical language and packages 
Statistical analysis was carried out in the R language version 3.0 (www.r-project.org), and R codes for 
SAM-GS and SAM-GSR algorithms were downloaded from Dr. Yasui’s webpage  
(http://www.ualberta.ca/~yyasui/homepage.html). Weighted co-expression networks were constructed 
using WGCNA package [40], feature selection in modified SAM-GSR algorithm was implemented 
using penalizedSVM package [41].   
 
Results and Conclusions 
Real data  
On the MSigDB C2 and C5 categories 
The study schema is presented in Figure 2. Upon gene sets in the MSigDB c2 category, we applied both 
SAM-GSR and modified SAM-GSR to the MS data. The selected pathways and genes by both 
algorithms are tabulated in Table 1. To evaluate both algorithms, we computed their predictive statistics 
on the training and test sets. As shown by the resulting statistics in Table 2A, modified SAM-GSR 
algorithm was superior to SAM-GSR algorithm in both the training set and the test set.  
 
Additionally, the parsimony of modified SAM-GSR algorithm suffered. We conjectured that this might 
result from the automatic determination of reduced subset size in modified SAM-GSR algorithm. In 
contrast, one explicit criterion chosen by us herein for reduced set determination in SAM-GSR 
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algorithm is parsimony. Moreover, the redundancy of information due to highly correlated genes in 
pathways may be attributable to the large size of reduced subset by modified SAM-GSR algorithm. On 
the contrary, SAM-GSR has more efficient control over this size by expelling genes with small values of 
individual SAM statistics outside.    
 
On weighted co-expression networks  
The curated pathways in major databases such as KEGG and GO tend to be enriched in the most 
prevalent-studied disease－cancers. This might put MS, a less investigated disease, in an inferior 
position. Especially when the goal is to incorporate the biological information involved in gene sets to 
improve upon predictive performance of a classifier, absence of such information might deteriorate the 
performance of a pathway-based feature selection algorithm. To evaluate if the deficiency of relevant 
pathways in the publicly available databases for MS has any impact on a pathway-based feature 
selection algorithm, we used weighted co-expression networks to cluster all genes annotated by 
HGU133plus2 package into 791 mutually exclusive subsets. Then, upon those gene subsets we 
reanalyzed the MS data using both SAM-GSR algorithms. The results are also presented in Table 2A.  
 
Interestingly, there was no overlap between two subsets identified by these two algorithms, and the 
modified SAM-GSR showed a comparable predictive performance upon both training and test data to 
that using c2 and c5 categories. As illustrated in Figure 3, 30 genes intersected with genes involving in 
MSigDB c2 category, and 13 were overlapped with genes in c5 category. However, those genes were 
not selected in the analyses using c2 and c5 categories, where the pathway information is incomplete 
and biased towards cancers.   
 
Comparing with the performance of other teams, we remark that if we had submitted the results of 
modified SAM-GSR analysis to sbv IMPROVER challenge, we would have been among top five. To 
conclude, complete pathway information is highly desired since the absence of meaningful biological 
information might result in declined discriminating capacity of a pathway-based feature selection 
algorithm. Provided such complete pathway information is unavailable currently, we suggest a statistical 
method is used for constructing statistical clusters, aiming at complementing those well-known 
biological pathways to achieve better performance.  
 
Comparison with other MS diagnosis signatures  
In this section, we compared several MS diagnosis signatures in the literatures with the ones we 
obtained using SAM-GSR algorithms. Here, we emphatically compared the performance of different 
signatures on the test set. The performance of those signatures by others were presented in Table 2B. 
Most relevantly, Guo et al. [42] obtained an 8-gene signature using the same training set. Then upon this 
8-gene signature, its performance on the test set was evaluated. Overall, It ranked as the second worst 
among those different signatures by outperforming our original submission to sbv IMPROVER 
challenge. In this submission, a feature selection algorithm called Threshold Gradient Descent 
Regularization (TGDR) [43] and an integrated data including 6 microarray studies were used. To 
evaluate if different training data may have influence on the performance of a classifier, we reran TGDR 
using the data of E-MTAB-69 as the training set. The predictive performance improved dramatically 
based on the statistics in Table 2B. This partially justified that there is always data dependency for a 
classifier [44] and that batch effect among different experiments should be handled with caution when 
those data sets are combined [45].  
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Synthesized data  
In Dinu et al [12], simulations were conducted to illustrate that SAM-GS algorithm outperforms GSEA 
in terms of identifying meaningful gene sets associated with the phenotype under study. Here since the 
focus was switched to explore the potential of SAM-GSR algorithms for feature selection, we conducted 
two simulations to explore if SAM-GSR algorithms can indeed distinguish true predictors apart from the 
false ones. Actual expression values of MS training data were used in the simulations, with an extra 
standardization to make the expression values of an individual gene have a mean of zero and a standard 
deviation of one. 
 
In the first simulation, we chose the two genes selected by Tarca et al [39], i.e., F13A1 and GSTM1. 
These two genes are annotated within MSigDB c2 category, c5 category and hgu133plus2.db package. 
Then we randomly selected 998 genes from MS training data, those genes served as noises. The logit 
function for MS patients with controls as the baseline was given as following,  
fMSvsControl =1.28XF13A1 −1.2XGSTM1
  
the values of coefficients of F13A1 and GSTM1 were simulated using an uniform distributed random 
variable in the range of -3 to 3. Furthermore, both genes are involved in many gene sets in both c2 (>40) 
and c5 (>20) categories.  
 
In the second simulation, we chose two genes that are only involved in one or two gene sets in c2 and c5 
categories as the relevant genes. The logit function for MS patients with controls as the baseline was 
given as following,  
fMSvsControl = −2.82XRP9 − 2.41XCOX 4 I 2  
the values before RP9 and COX4I2 were simulated using an uniform distributed random variable in the 
range of -3 to 3, again. 
 
The results are tabulated in Table 3. An important finding here is when the true marker appears in many 
gene sets, SAM-GSR algorithm can easily identify it while modified SAM-GSR might miss it with high 
probability. Oppositely, when the true marker is rarely involved in several gene sets both SAM-GSR 
algorithms are highly likely to miss it. This explains why when the mutually exclusive gene sets 
constructed by co-expression network method were used, both SAM-GSR algorithms failed to identify 
at least one of two considered genes.  
 
Another finding is the size of selected gene subset by SAM-GSR algorithm is substantially smaller than 
that by modified one, typically in the first extreme case where the true markers are involved in many 
gene sets. This is in consistent with the results of MS application. We remark this is because when a 
gene is involved in many gene sets, its probability of being selected increases. Namely, the chance of 
this gene having a big enough SAM statistic in several gene sets is obviously bigger than in one gene set.  
 
Discussion 
Using a real-world application of a MS microarray data, modified SAM-GSR algorithm on complete co-
expression network with the aid of a statistical method established excellent predictive performance.  
Based on the results from two simulations, we found modified SAM-GSR algorithm has two obvious 
drawbacks compared to SAM-GSR. One is high likelihood of failing to identify true markers and the 
other is poor control over the resulting subset size. However, these drawbacks are extrusive in the cases 
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when true marker appears in many gene sets. On the opposite condition when true marker appears in 
rare gene sets, SAM-GSR algorithm also is ineluctable from missing true markers.   
 
Given the fact the complete pathway information is far from completeness, a statistical method capable 
of constructing biologically meaningful gene networks is in demand. Based on the simulations, we 
hypothesize that a more complicated method than weighted co-expression network algorithm, which 
only considers correlations among genes in essence, may complement those annotated gene sets in 
relevant databases to produce a better classifier. The basic requirement for such method is it must take 
interactions and interplay among genes into account.   
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Tables 
Table 1. The selected pathways and genes in MS data  
 Pathways by SAM-GS   Genes by SAM-GSR  Genes by modified SAM-GSR  
C2  R: base excision repair, resolution of AP sites 
via the multiple nucleotide patch replacement,  
processive synthesis on the lagging strand,  
pol switching, repair synthesis for gap filling by 
DNA pol in TC NER, unwinding of DNA, 
removal of the flap intermediate from the C 
strand, DNA strand elongation, CD28 
dependent P13K AKT signaling   
O:  Okamoto liver cancer multi-centric 
occurrence down * 
 
Note: the cutoff of Q-value is 0.05. 
POLD4 POLD2 POLD1 
NTHL1 DNA2 MLST8 
AKT3 RICTOR POLE 
MCM3 MCM5 GINS2 
MCM2 RPA3 CLEC10A 
TAPBP TRIM25 
AKAP17A 
 
Note: the cutoff of Ck is 0.2 
 
 
(N=288, n=18) ** 
 
Note: Since there are 271 genes in this 
final model and the performance of this 
model is inferior to others, the resulting 
genes are not presented here.  
 
 
(N=288, n=271 using SCAD as penalty 
and n=112 using LASSO as penalty) 
C5  Transcription factor TFIID complex, amino acid 
derivative biosynthetic process, transcription 
from RNA polymerase activity, DNA 
polymerase activity, DNA directed DNA 
polymerase activity   
  
Note: the cutoff of p-value is 0.01, if based on Q-
value<0.05, No gene set is significant.   
ASMTL POLR2K ZNF76 
BRCA1 TAF1 TAF11 
EDF1 POLD4 
 
Note: the cutoff of Ck is 0.05. 
 
(N=59, n=8) ** 
 
TAF1 TAF6 TAF5 TAF8 TAF11 TAF10 
TAF13 TAF12 EDF1 TAF9 OAZ1 
GATM ASMTL ETNK1 TGFB2 GTF3A 
POLR2L POLR2K SNAPC4 ZNF76 
SNAPC3 POLR3C BRCA1 TROVE2 
GTF3C4 PTGES3 POLI POLH POLE 
POLA1 POLD4 POLE4 POLE2 POLE3 
POLD1 TEP1 POLG2 POLQ  
TERT REV3L 
 
 (N=59, n=40)  
CN1 NA  ***  
 
Note: all genes were classified into 731 mutually exclusive 
get sets with the minimum size of 10, SAM-GS selected 4 
of them.  
LGALS3 RCL1 MSLN 
GLUL IKBIP RP2 
 
Note: the cutoff of Ck is 0.2. 
 
(N=95, n=6) ** 
ACVR2B CHMP4A EIF3J-AS1 ETV7 
FANCE HOXC5 LINC00482   
MCM3AP-AS1 PDCD4 PRCC 
SLC39A13 TTC9C VPS26B CD1C 
COQ6 DNPH1 EDEM2 HLA-DOA 
MLST8 POLR2E PSENEN SPINT2 
TMC6 ACTL10 HIST1H1A KRBA1 
SPRYD3 UBOX5 CHID1 GID4 LNX1 
SGK494 TAF15 TRDMT1 
 
(N=95, n=34) 
Note: * R stands for the pathways in Reactome; O is for the ones manually curated from the literature on gene expression in MSigDB c2 category. ** N 
represents the total number of unique genes annotated by hgu133plus2.db package in the selected pathways. *** NA stands for Not Applicable. Moreover, 
gene symbols in purple are the genes indicated as directly related to MS by the GeneCards database. The overlapped gene symbols between SAM-GSR 
and modified SAM-GSR were highlighted. 1 CN abbreviates for the gene sets constructing by the weighted co-expression network algorithm.   
 
Table 2. The performance statistics of selected genes on MS training and test sets  
 Training set Test set 
 Error (%) GBS BCM AUPR Error (%) GBS BCM AUPR 
A. The performance of SAM-GSR and modified SAM-GSR 
C2: SAM-GSR 20.45 0.121 0.701 0.896 46.67 0.464 0.500 0.644 
M-SAM-GSR 0 0.066 0.747 0.992 46.67 0.291 0.520 0.612 
Lasso as penalty  0 0.083 0.719 0.992 33.33 0.207 0.564 0.776 
C5:  SAM-GSR 13.64 0.134 0.673 0.904 46.67 0.464 0.500 0.579 
M-SAM-GSR 0 0.046 0.800 0.992 43.33 0.365 0.577 0.703 
CN:  SAM-GSR 11.36 0.138 0.669 0.858 46.67 0.439 0.506 0.608 
    M -SAM-GSR  0 0.013 0.985 0.992 33.33 0.292 0.659 0.647 
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B. The performance of other relevant signatures  
Study ( size ) Training data used  Error (%) GBS BCM AUPR 
Lauria (n>100) E-MTAB-69 -- -- 0.884 0.874 
Tarca (n=2) GSE21942 (on Human Gene 1.0 ST) -- -- 0.629 0.819 
Zhao (n=58) 
        (n=84)  7 other data besides E-MTAB-69  
30 
35 
-- 
-- 
0.576 
0.549 
0.820 
0.636 
Tian (n=28 )1 
        (n=38 )2 
5 other data besides E-MTAB-69 
E-MTAB-69 only 
68.33 
38.33 
0.546 
0.290 
0.345 
0.559 
0.362 
0.593 
Guo  (n=8) E-MTAB-69   * 
(10-fold CV error=13.64 %)  
46.67 0.462 0.499 0.504 
Note: C2 represents the analysis using the pathways in MSigDB c2 category; C5 represents the analysis using the pathways in MSigDB c5 category; CN 
represents the analysis using the gene sets constructed by the weighted co-expression network algorithm. M-SAM-GSR abbreviates for modified SAM-
GSR algorithm. GBS: Generalized Brier Score; BCM: Belief Confusion Metric; AUPR: Area Under the Precision-Recall Curve. * The predictive statistics on 
the test set for Guo’s study were calculated based on the 8-gene signature they provided in their article. 1This was the original submission by us to sbv 
IMPROVER using TGDR algorithm, it was ranked around 30 among 54 participants. 2This was the reanalysis we did on the training set using TGDR to 
evaluate how the use of different training sets affects the performance of an algorithm.   
 
Table 3. The performance of SAM-GSR and modified SAM-GSR on simulated data   
 SAM-GSR Modified SAM-GSR  
A. Simulation 1 (q-value in SAM-GS <0.05)  
 F13A1 GSTM1 Size F13A1 GSTM1 Size  
C2 Yes Yes 13 No Yes 35 
C5 Yes Yes  14 No No 42 
CN Yes No 11 No No 47 
B. Simulation 2  
 RP9 COX4I2 Size RP9 COX4I2 Size  
C2 No Yes 3 No Yes 3 
C5 No Yes 2 No Yes 4 
CN1  No Yes 4 No Yes 36 
Note: Yes represents the gene is selected by algorithms; No means the gene is not selected; Size refers to the size of the reduced gene subset. 1 here, p-
value <0.1 instead of q-value<0.05 in SAM-GS was chosen because there was no gene sets selected if using q-value.  
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Figures 
Figure 1. Graphical illustration of both SAM-GSR and modified SAM-GSR algorithms. A. SAM-
GSR for feature selection. B. Modified SAM-GSR.   
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Figure 2. Study schema illustrating how the analyses were conducted on the multiple sclerosis 
microarray data.  
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Figure 3. Venn-diagram showing how the 34-gene signature selected by modified SAM-GSR 
algorithm intersected with genes annotated by MSigDB c2, c5 category and hgu133plus2 
package. 
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